WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for Revolution Medicines, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-12 10:34 am Sale | 2025-06-30 | 13G | Revolution Medicines, Inc. RVMD | WELLINGTON MANAGEMENT GROUP LLP | 10,259,738 5.500% | -1,141,656 (-10.01%) | Filing |
| 2024-11-08 10:52 am Sale | 2024-09-30 | 13G | Revolution Medicines, Inc. RVMD | WELLINGTON MANAGEMENT GROUP LLP | 11,401,394 6.830% | -3,480,692 (-23.39%) | Filing |
| 2024-02-08 10:17 am Purchase | 2023-12-29 | 13G | Revolution Medicines, Inc. RVMD | WELLINGTON MANAGEMENT GROUP LLP | 14,882,086 9.090% | 662,656 (+4.66%) | Filing |
| 2023-11-09 1:26 pm Purchase | 2023-10-31 | 13G | Revolution Medicines, Inc. RVMD | WELLINGTON MANAGEMENT GROUP LLP | 14,219,430 12.990% | 5,345,456 (+60.24%) | Filing |
| 2023-02-06 2:56 pm Sale | 2022-12-30 | 13G | Revolution Medicines, Inc. RVMD | WELLINGTON MANAGEMENT GROUP LLP | 8,873,974 9.990% | -62,495 (-0.70%) | Filing |
| 2022-12-09 1:50 pm Purchase | 2022-11-30 | 13G | Revolution Medicines, Inc. RVMD | WELLINGTON MANAGEMENT GROUP LLP | 8,936,469 10.060% | 4,425,574 (+98.11%) | Filing |
| 2022-02-04 09:22 am Purchase | 2021-12-31 | 13G | Revolution Medicines, Inc. RVMD | WELLINGTON MANAGEMENT GROUP LLP | 4,510,895 6.120% | 4,510,895 (New Position) | Filing |